Search company, investor...

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Dead | Dead

Total Raised


About Cure Forward Corp.

Cure Forward is a digital health company combining genomics and social media to make personalized medicine work for patients, their family caregivers, and physicians. Cure Forward solves two urgent problems: making complex genomic test results practically useful, and filling biomarker-selective trials.

Cure Forward Corp. Headquarters Location

263 Summer Street 4th Floor

Boston, Massachusetts, 02210,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cure Forward Corp.

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cure Forward Corp. is included in 2 Expert Collections, including Omics.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Digital Health

13,113 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Cure Forward Corp. Patents

Cure Forward Corp. has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics



Drug discovery, Pharmaceutical industry, Clinical research, Life sciences industry, Biotechnology


Application Date


Grant Date


Related Topics

Drug discovery, Pharmaceutical industry, Clinical research, Life sciences industry, Biotechnology



Latest Cure Forward Corp. News

Cure Forward Receives $15 Million in Series A Financing

Dec 4, 2020

June 18, 2015 08:15 AM Eastern Daylight Time CAMBRIDGE, Mass.--( BUSINESS WIRE )--Cure Forward, a privately held Patient Activation Company, announced today that it has secured $15 million in a Series A financing. Apple Tree Partners, which is the sole investor in Cure Forward, officially launches the Company with this commitment. Proceeds will be used to create a multisided technology platform for healthcare built around the science and technology of precision medicine. Cure Forward will harness molecular science to connect patients with relevant information, treatment options, and other patients with similar characteristics, making patient participation in precision healthcare possible. “We believe there is an entirely new way for people to approach their disease. What Cure Forward will accomplish will be much like Airbnb and Kickstarter, technology platforms that connect people in new ways. We are using scientific information to bring together audiences that previously had no way of finding each other, and when they can, it will unleash enormous value and accelerate cures," said Martin Naley, CEO of Cure Forward. Cure Forward is currently in a private beta and will launch in September of 2015. "Apple Tree Partners is dedicated to creating and building transformational healthcare companies. We are thrilled to have supported Cure Forward throughout its journey from a promising concept to a groundbreaking technology platform with a broad range of possibilities, all of which have the potential to improve the lives of so many patients. The world of precision medicine is evolving rapidly and we believe Cure Forward addresses a profound need to connect patients with therapies tailored specifically to their disease. Empowering patients with this access will further accelerate the innovative research needed to advance toward cures and, most importantly, save lives," said Aaron Kantoff, Vice President of Apple Tree Partners and a Director at Cure Forward. For more information please visit our website . About Apple Tree Partners Apple Tree Partners (ATP) is a leading venture capital firm dedicated to building healthcare businesses. ATP has deep sector expertise across healthcare services, pharmaceuticals, biotech, and medtech. Founded in 1999, ATP has a well-known history of successfully partnering with management teams and taking the long view as a matter of principle for value creation. ATP raised its fourth fund in 2012 totaling $1.5 billion and is actively funding healthcare innovation. ATP is headquartered in New York City with satellite offices in Princeton, NJ and Cambridge, MA. For more information, please visit our website . About Cure Forward Cure Forward is a patient activation company bringing together science, community and education, giving patients unprecedented ability to utilize their molecular test data. Through the company’s website, patients can connect with relevant information, treatment options, and other similar patients. Cure Forward makes personalized healthcare accessible and approachable for patients and caregivers, activating their potential for cure or action against their disease. Cure Forward was incubated and launched by Apple Tree Partners, a leading healthcare venture capital firm headquartered in New York City. For more information, visit .

  • Where is Cure Forward Corp.'s headquarters?

    Cure Forward Corp.'s headquarters is located at 263 Summer Street, Boston.

  • What is Cure Forward Corp.'s latest funding round?

    Cure Forward Corp.'s latest funding round is Dead.

  • How much did Cure Forward Corp. raise?

    Cure Forward Corp. raised a total of $27.83M.

  • Who are the investors of Cure Forward Corp.?

    Investors of Cure Forward Corp. include Apple Tree Partners.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.